Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Porous chitin nanofibers combined with adipose-derived stem cells promote diabetic wound healing via PPAR-γ activation.

Zhang Z., Zheng Y., Wang Z., Li Y., Liu Y., Luo Z.

Animal Study on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int J Biol Macromol (2025)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
40976300
DOI
10.1016/j.ijbiomac.2025.147763

Abstract (original English)

Chronic wounds of diabetes are one of the serious complications that cause disability or death in patients with diabetes, posing a significant clinical challenge. Therefore, porous chitin nanofibers (CR) were prepared from silk and squid cartilage, and combined with adipose-derived stem cells (ADSCs) transplantation to promote wound healing in type 2 diabetes mellitus (T2DM) in this study. The results of scanning electron microscopy (SEM), fourier transform infrared spectroscopy (FTIR), and X-ray diffraction (XRD) indicated that the CR had an obvious three-dimensional porous structure. The in vivo and in vitro degradation experiments showed that the CR had good degradability. The live/dead staining and hemolysis experiments demonstrated that the CR had good biocompatibility. The results of in vivo experiments indicated the results of H&E staining and masson staining indicated that the CR combined with the ADSCs transplantation significantly accelerated the wound healing of T2DM mice. Immunohistochemical staining indicated that the CR combined with the ADSCs transplantation significantly increased collagen deposition and cell proliferation, and regulated macrophage expression. In addition, the CR combined with the ADSCs transplantation can increase the expression of α-SMA and VEGF-A to promote angiogenesis. Proteomics sequencing and western blotting experiments revealed that the

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsWound HealingNanofibersChitinPPAR gammaMicePorosityAdipose TissueStem CellsDiabetes Mellitus, Type 2

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research